Welcome to the Emerging Pathogens & Infectious Diseases Consortium
Welcome to EPIC – the Emerging Pathogens and Infectious Diseases Consortium.
EPIC brings together researchers, clinicians, and institutions across the University of Toronto and its hospital partners to advance infectious disease research and build lasting resilience against emerging threats.
This work builds on a long legacy: EPIC partners have played an integral role in infectious disease research for a century, from work that helped control diphtheria and eradicate smallpox, to today’s front-line research in antimicrobial resistance and infection control. Our collective response to COVID-19, highly pathogenic avian influenza, and mpox makes clear there’s never been a more important time to advance that work, from emerging pathogens and antimicrobial resistance to health inequities and public trust.
Building on this momentum, EPIC marshals the advanced research infrastructure and world-renowned research and training expertise of our EPIC partners to deliver an integrated, innovative response to the infectious disease challenges facing communities today and in the future.
Seven EPIC research clusters
Antimicrobial resistance
Protecting the effectiveness of the medicines we depend on.
Chronic infections and long-term sequelae
Addressing the long-term burden of infections that don’t resolve.
Emerging and re-emerging pathogens
Detecting and responding to new and re-emerging threats before they spread.
Health inequities
Ensuring infectious disease research and response reach everyone, equitably.
Health systems resilience
Building health systems that bend, not break, under infectious threats.
Misinformation, disinformation and public trust
Strengthening public trust through clear, credible information.
Sepsis and acute infections
Improving detection and treatment when every minute counts.
EPIC News
Member Spotlight: Susy Hota
Meet Susy Hota, medical director of Infection Prevention and Control and an infectious disease specialist at the University Health Network. She is also an associate professor in the department of medicine at the Temerty Faculty of Medicine at the University of Toronto and co-lead of the University of Toronto Microbiota Therapeutics Outcomes Program.
EPIC co-hosts roundtable with Lorne Tyrrell on the future of infectious diseases research and innovation in Canada
On Nov. 16, EPIC co-hosted a breakfast roundtable honouring Lorne Tyrrell, winner of the 2021 Henry G. Friesen International Prize in Health Research. The roundtable discussion focused on the future of infectious diseases research and innovation in Canada and what lessons could be learned from the COVID-19 pandemic as we move forward.
World Antimicrobial Awareness Week: How U of T researchers are tackling the global challenge of antimicrobial resistance
As the global health and research communities mark World Antimicrobial Awareness Week, members of the Emerging and Pandemic Infections Consortium (EPIC) are making strides in the fight against antimicrobial resistance. L
